Association between preeclampsia and congenital heart defects

JAMA - Journal of the American Medical Association

Volumn 314, Issue 15, 2015, Pages 1588-1598

  Auger, Nathalie ^a,b   Fraser, William D ^a,c   Healy Profitós, Jessica ^a   Arbour, Laura ^d  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CONGENITAL HEART MALFORMATION; DISEASE ASSOCIATION; DISEASE COURSE; ECLAMPSIA; FEMALE; GESTATIONAL AGE; HEART SEPTUM DEFECT; HOSPITAL DISCHARGE; HUMAN; INFANT; LIVE BIRTH; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; PROGENY; ADULT; HEART DEFECTS, CONGENITAL; NEWBORN; PRE-ECLAMPSIA; PREGNANCY; RETROSPECTIVE STUDY; RISK; YOUNG ADULT;

ADULT; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREVALENCE; QUEBEC; RETROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 84944585152     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.12505     Document Type: Article

References (31)

1. van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241-2247.
2. Khoshnood B, Lelong N, Houyel L, et al; EPICARD Study Group. Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study. Heart. 2012;98(22):1667-1673.
3. van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJ. The changing epidemiology of congenital heart disease. Nat Rev Cardiol. 2011;8(1):50-60.
4. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115(2):163-172.
5. Lu Y, Agrawal G, Lin CW, Williams RG. Inpatient admissions and costs of congenital heart disease from adolescence to young adulthood. Am Heart J. 2014;168(6):948-955.
6. Ávila P, Mercier LA, Dore A, et al. Adult congenital heart disease: a growing epidemic. Can J Cardiol. 2014;30(12)(suppl):S410-S419.
7. Liu S, Joseph KS, Lisonkova S, et al; Canadian Perinatal Surveillance System (Public Health Agency of Canada). Association between maternal chronic conditions and congenital heart defects: a population-based cohort study. Circulation. 2013; 128(6):583-589.
8. Llurba E, Sánchez O, Ferrer Q, et al. Maternal and foetal angiogenic imbalance in congenital heart defects. Eur Heart J. 2014;35(11):701-707.
9. Sliwa K, Mebazaa A. Possible joint pathways of early pre-eclampsia and congenital heart defects via angiogenic imbalance and potential evidence for cardio-placental syndrome. Eur Heart J. 2014;35 (11):680-682.
10. von Dadelszen P, Magee LA. Pre-eclampsia: an update. Curr Hypertens Rep. 2014;16(8):454.
11. van Gelder MM, Van Bennekom CM, Louik C, Werler MM, Roeleveld N, Mitchell AA. Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study. BJOG. 2015;122(7):1002-1009.
12. Roberts JM, Bell MJ. If we know so much about preeclampsia, why haven't we cured the disease? J Reprod Immunol. 2013;99(1-2):1-9.
13. Auger N, Le TU, Park AL, Luo ZC. Association between maternal comorbidity and preterm birth by severity and clinical subtype: retrospective cohort study. BMC Pregnancy Childbirth. 2011;11:67.
14. Bruneau BG. The developmental genetics of congenital heart disease. Nature. 2008;451(7181): 943-948.
15. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785-799.
16. Magee LA, Helewa M, Moutquin JM, von Dadelszen P; Hypertension Guideline Committee; Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 2008;30(3)(suppl):S1-S48.
17. Melamed N, Ray JG, Hladunewich M, Cox B, Kingdom JC. Gestational hypertension and preeclampsia: are they the same disease? J Obstet Gynaecol Can. 2014;36(7):642-647.
18. Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1-544.e12.
19. Auger N, Park AL, Gamache P, Pampalon R, Daniel M. Weighing the contributions of material and social area deprivation to preterm birth. Soc Sci Med. 2012;75(6):1032-1037.
20. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986; 73(1):13-22.
21. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706.
22. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010;122(5): 478-487.
23. Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011;31 (1):33-46.
24. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376 (9741):631-644.
25. Steinberg G, Khankin EV, Karumanchi SA. Angiogenic factors and preeclampsia. Thromb Res. 2009;123(suppl 2):S93-S99.
26. Sugimoto M, Oka H, Kajihama A, et al. Ratio between fms-like tyrosine kinase 1 and placental growth factor in children with congenital heart disease. Pediatr Cardiol. 2015;36(3):591-599.
27. Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497-506.
28. Fox NS, Saltzman DH, Oppal S, Klauser CK, Gupta S, Rebarber A. The relationship between preeclampsia and intrauterine growth restriction in twin pregnancies. Am J Obstet Gynecol. 2014;211 (4):422.e1-422.e5.
29. Dhanantwari P, Lee E, Krishnan A, et al. Human cardiac development in the first trimester: a high-resolution magnetic resonance imaging and episcopic fluorescence image capture atlas. Circulation. 2009;120(4):343-351.
30. Bourke J, Bower C, Blair E, Charles A, Knuiman M. The effect of terminations of pregnancy for fetal abnormalities on trends in mortality to one year of age in Western Australia. Paediatr Perinat Epidemiol. 2005;19(4):284-293.
31. Forrester MB, Merz RD, Yoon PW. Impact of prenatal diagnosis and elective termination on the prevalence of selected birth defects in Hawaii. Am J Epidemiol. 1998;148(12):1206-1211.